Melanoma Clinical Trials in California

Showing 161-170 of 170 trials

Phase II Trial of Allovectin-7® for Metastatic Melanoma

NCT00044356

The purpose of this clinical trial is to determine if Allovectin-7®, an experimental gene-based immunotherapy, can shrink melanoma tumors. The trial will also examine if this treatment can improve the time to disease progression.

MelanomaMetastatic MelanomaMalignant Melanoma+1 more

Vical133 participantsStarted Feb 2001

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Bakersfield, California, United States +13 more locations

COMPLETEDPhase 363 miles

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00003647

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Injecting allovectin-7 into a person's melanoma cells may make the body build an immune response that will kill tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of dacarbazine with or without immunotherapy in treating patients who have stage III or stage IV melanoma.

Stage IV MelanomaStage III MelanomaRecurrent Melanoma

VicalStarted Jul 1998

Little Rock, Arkansas, United States • Bakersfield, California, United States • Encinitas, California, United States +41 more locations

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma Trials in Other Cities

Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Study of CP-675,206 in Refractory Melanoma

Long-term Data Collection for Subjects in MDX-010 Studies

Vaccine Therapy for Patients With Stage IV Melanoma

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Other Conditions in California